Deficiency of muscular dystrophy–related gene JAG2 causes NOTCH signaling dysfunction in muscle stem cells
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci198639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Minoru Tanaka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Institute and. Hauptthemen laut MEDLINE: Jagged-2 Protein, Receptors, Notch, Signal Transduction, Satellite Cells, Skeletal Muscle. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
We previously identified a muscular dystrophy caused by biallelic variants in JAGGED2 ( JAG2 ), whose protein product, JAG2, is a canonical NOTCH ligand. However, the disease mechanism remains unclear, particularly with respect to muscle stem cell (muscle satellite cell/MuSC) function and muscle regeneration. We examined the consequences of JAG2 deficiency and modeled pathogenic JAG2 variants in vitro and in vivo, the latter in mouse and fly models and with particular attention to the MuSC–muscle endothelial cell (MuEC) niche. We found that both Jag2 deficiency and overexpression of pathogenic JAG2 variants impaired NOTCH signaling and myogenic self-renewal and differentiation. Hypomorphic Jag2 mutant ( Jag2 sm ) mice displayed depleted MuSCs, corresponding with impaired muscle regeneration in those mice. Coculture experiments and the examination of cell type–specific Jag2 conditional knockout mice demonstrated that MuEC-specific Jag2 knockout resulted in reduced MuSC self-renewal, while MuSC-specific Jag2 knockout resulted in reduced myogenic differentiation. Human reference JAG2 , but not human pathogenic variants of JAG2 , rescued the deficiency of Serrate , the Drosophila ortholog of JAG2 . Therefore, pathogenic variants in JAG2 impair muscle development and regeneration through disrupted cell-autonomous cis- inhibition and nonautonomous trans- activation involving NOTCH signaling dysfunction. Our findings indicate that optimizing JAG2-mediated NOTCH signaling is a potential therapeutic approach for JAG2 -related muscular dystrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell Institute and.
- Greg Marzolf Jr. Muscular Dystrophy Center and Department of Neurology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota College of Pharmacy, Duluth, Minnesota, USA.
- Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA.
- Institute for Translational Neuroscience, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Förderung
- National Institutes of Health
Zitieren
APA
Tanaka, M., Kim, N. C., Draper, I., Littel, H. R., Gunasekaran, M., Turner, J., Wells, N. M., Mujteba, Q., Asakura, Y., Kang, P. B., & Asakura, A. (2026). Deficiency of muscular dystrophy–related gene JAG2 causes NOTCH signaling dysfunction in muscle stem cells. Journal of Clinical Investigation. https://doi.org/10.1172/jci198639
Vancouver
Tanaka M, Kim NC, Draper I, Littel HR, Gunasekaran M, Turner J, et al. Deficiency of muscular dystrophy–related gene JAG2 causes NOTCH signaling dysfunction in muscle stem cells. Journal of Clinical Investigation. 2026. doi:10.1172/jci198639
BibTeX
@article{Tanaka2026,
author = {Tanaka, Minoru and Kim, Nam Chul and Draper, Isabelle and Littel, Hannah R and Gunasekaran, Mekala and Turner, Johnnie and Wells, Natalya M and Mujteba, Qasim and Asakura, Yoko and Kang, Peter B and Asakura, Atsushi},
title = {Deficiency of muscular dystrophy–related gene JAG2 causes NOTCH signaling dysfunction in muscle stem cells},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci198639}
}
EUVIMED